Clinical Trial Update: Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the impact of pharmacogenetic-guided treatment for Type 2 diabetes. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia | Conditions: Diabetes Mellitus Type 2 | Phase 4 | Status: ACTIVE_NOT_RECRUITING